These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2660047)

  • 21. Phase II clinical study of tamoxifen in advanced endometrial adenocarcinoma: a Gynecologic Oncology Group study.
    Slavik M; Petty WM; Blessing JA; Creasman WT; Homesley HD
    Cancer Treat Rep; 1984 May; 68(5):809-11. PubMed ID: 6722836
    [No Abstract]   [Full Text] [Related]  

  • 22. Medrogestone therapy in advanced endometrial adenocarcinoma.
    Waterman EA; Benson RC
    Obstet Gynecol; 1967 Nov; 30(5):626-34. PubMed ID: 4167865
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of cisplatin, doxorubicin, and cyclophosphamide to treat advanced and recurrent adenocarcinoma of the endometrium.
    Hancock KC; Freedman RS; Edwards CL; Rutledge FN
    Cancer Treat Rep; 1986 Jun; 70(6):789-91. PubMed ID: 3731140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preliminary report on the use of corpus luteum in the cancerology of the endometrium and breast].
    Hakami T; Demers FX
    Laval Med; 1967 May; 38(5):450-3. PubMed ID: 5606156
    [No Abstract]   [Full Text] [Related]  

  • 25. A trial of continuous-infusion vinblastine in refractory endometrial adenocarcinoma.
    Kavanagh JJ; Saul PB; Wharton JT; Rutledge FN
    Gynecol Oncol; 1987 Feb; 26(2):236-9. PubMed ID: 3804040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Results of the treatment of adenocarcinoma of the endometrium].
    Vera González JA; Saavedra Macaya R; Saavedra Yáñez F; Ossandón Guzmán M
    Rev Chil Obstet Ginecol; 1985; 50(4):305-16. PubMed ID: 3843281
    [No Abstract]   [Full Text] [Related]  

  • 27. Mitoxantrone: modest activity in a phase II trial in advanced prostate cancer.
    Osborne CK; Drelichman A; Von Hoff DD; Crawford ED
    Cancer Treat Rep; 1983 Dec; 67(12):1133-5. PubMed ID: 6652630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II trial of mitoxantrone in advanced colorectal cancer.
    Bonnem EM; Mitchell EP; Woolley PV; Smith FP; Neefe J; Smith L; Schein PS
    Cancer Treat Rep; 1982 Nov; 66(11):1995-6. PubMed ID: 7139642
    [No Abstract]   [Full Text] [Related]  

  • 29. Progestins in the treatment of endometrial carcinoma.
    Anderson DG
    Surg Forum; 1965; 16():398-400. PubMed ID: 5835208
    [No Abstract]   [Full Text] [Related]  

  • 30. [MAP in the treatment of adenocarcinoma of the endometrium].
    Leone F; De Placido G; Frollo G
    Minerva Ginecol; 1979 Apr; 31(4):251-5. PubMed ID: 460664
    [No Abstract]   [Full Text] [Related]  

  • 31. Phase II evaluation of mitoxantrone in advanced carcinoma of the stomach: a Southeastern Cancer Study Group Trial.
    DeSimone PA; Gams R; Birch R
    Cancer Treat Rep; 1986 Aug; 70(8):1043-4. PubMed ID: 3524836
    [No Abstract]   [Full Text] [Related]  

  • 32. Endometrial cancer: approach to development of effective chemotherapy.
    Carbone PP; Carter SK
    Gynecol Oncol; 1974 Aug; 2(2-3):348-53. PubMed ID: 4480369
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of progestational agents in the management of endometrial cancer.
    Kistner RW; Griffiths CT; Craig JM
    Cancer; 1965 Dec; 18(12):1563-79. PubMed ID: 5891823
    [No Abstract]   [Full Text] [Related]  

  • 34. Phase II clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study.
    Taylor SA; Von Hoff DD; Baker LH; Balcerzak SP
    Cancer Treat Rep; 1984 Jun; 68(6):919-20. PubMed ID: 6733708
    [No Abstract]   [Full Text] [Related]  

  • 35. Mitoxantrone in advanced cervical carcinoma: a phase II study in patients not previously treated with chemotherapy.
    Hørding U; Rose C; Jakobsen K; Dirksen H
    Cancer Treat Rep; 1986 Oct; 70(10):1239-40. PubMed ID: 3756944
    [No Abstract]   [Full Text] [Related]  

  • 36. [Use of a new synthetic progestative agent in high dosage (ethynodiol diacetate) in the treatment of advanced forms of adenocarcinoma of the corpus uteri (apropos of 2 illustrative cases)].
    Luzuy M; Soutoul JH; Luzuy R
    Chirurgie; 1970 Oct; 96(12):859-67. PubMed ID: 5502831
    [No Abstract]   [Full Text] [Related]  

  • 37. Combination chemotherapy of advanced endometrial adenocarcinoma with adriamycin, cyclophosphamide, 5-fluorouracil, and medroxyprogesterone acetate.
    Bruckner HW; Deppe G
    Obstet Gynecol; 1977 Jul; 50(1 Suppl):10s-12s. PubMed ID: 876531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of medroxyprogesterone (MAP) therapy on the DNA content in adenocarcinoma of the human endometrium].
    Vecchietti G; Gerzeli G; Zanoio L; Novelli GG; Barni S
    Minerva Ginecol; 1979; 31(7-8):597-603. PubMed ID: 481819
    [No Abstract]   [Full Text] [Related]  

  • 39. 17-alpha-hydroxyprogesterone caproate treatment of gynecologic cancer.
    Hreshchyshyn MM; Graham RM
    Am J Obstet Gynecol; 1969 Jul; 104(6):916-8. PubMed ID: 5792777
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of advanced adenocarcinoma of the endometrium with melphalan, 5-fluorouracil, and medroxyprogesterone acetate: a preliminary study.
    Cohen CJ; Deppe G; Bruckner HW
    Obstet Gynecol; 1977 Oct; 50(4):415-7. PubMed ID: 904803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.